The potential of genomics for infectious disease forecasting.
Jessica E StockdalePengyu LiuCaroline ColijnPublished in: Nature microbiology (2022)
Genomic technologies have led to tremendous gains in understanding how pathogens function, evolve and interact. Pathogen diversity is now measurable at high precision and resolution, in part because over the past decade, sequencing technologies have increased in speed and capacity, at decreased cost. Alongside this, the use of models that can forecast emergence and size of infectious disease outbreaks has risen, highlighted by the coronavirus disease 2019 pandemic but also due to modelling advances that allow for rapid estimates in emerging outbreaks to inform monitoring, coordination and resource deployment. However, genomics studies have remained largely retrospective. While they contain high-resolution views of pathogen diversification and evolution in the context of selection, they are often not aligned with designing interventions. This is a missed opportunity because pathogen diversification is at the core of the most pressing infectious public health challenges, and interventions need to take the mechanisms of virulence and understanding of pathogen diversification into account. In this Perspective, we assess these converging fields, discuss current challenges facing both surveillance specialists and modellers who want to harness genomic data, and propose next steps for integrating longitudinally sampled genomic data with statistical learning and interpretable modelling to make reliable predictions into the future.
Keyphrases
- infectious diseases
- coronavirus disease
- public health
- candida albicans
- single cell
- high resolution
- copy number
- physical activity
- electronic health record
- sars cov
- biofilm formation
- escherichia coli
- big data
- staphylococcus aureus
- gram negative
- mass spectrometry
- gene expression
- global health
- single molecule
- quantum dots
- tandem mass spectrometry
- liquid chromatography
- risk assessment